This presentation assesses the role of liver transplantation in treating end-stage liver disease today. Most of the unresolved issues in human liver transplantation have been developed in two major series, the one from Denver and the other from the combined Cambridge/Kings College Hospital effort in England. The findings of these groups are highlighted, as are the changes in technique that have...

Peter L. Tyack, Andreas Fahlman, Michael Moore, and Darlene Ketten Woods Hole Oceanographic Institution 266 Woods Hole Road, MS #50 Woods Hole MA 02543 phone: (508) 289-2818 fax: (508) 457-2041 email: [email protected] phone: (508) 289-3463 fax: (508) 457-2041 email: [email protected] phone: (508) 289-3228 fax: (508) 457-2041 email: [email protected] phone: (508) 289-2731 fax: (508) 457-2041 email:...

Nonlinear adaptive filtering techniques, based on the Volterra model, are widely used for the nonlinearities identification in many applications. This paper proposes a new implementation of the third order LMS Volterra filter. A third order nonlinear system with memory is identified using the new LMS algorithm implementation for the Volterra kernels estimation. The accuracy of the proposed algo...

OBJECTIVE Increasing evidence has informed that dysregulation of microRNAs (miRNAs) may contribute to carcinogenesis in human. The aim of the present study was to determine the role of miR-508-5p in glioma. PATIENTS AND METHODS Quantitative real-time PCR was performed to detect the expression levels of miR-508-5p in glioma and normal control tissues. In vitro, migration assays and a wound-hea...

Multidrug resistance (MDR) correlates with treatment failure and poor prognosis among gastric cancer (GC) patients. In a previous study using high-throughput functional screening, we identified 11 microRNAs (miRNAs) that regulate MDR in GC and found that miR-508-5p reversed MDR by targeting ABCB1 and ZNRD1. However, the mechanism by which miR-508-5p was decreased in chemo-resistant GC cells was...

PAGE INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 503 The allelomorph A b . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . The allelomorph ap. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Dominance. . . . . . . . . . . . . . . . . ...

Authors' A Mortimer Experimen Medicine, M Correspon Medical Re 508, 3999 1E2. Phon antonis.kor Medical Re 508, 3999 1E2. Phon swang@ldi.